VT
Viking Therapeutics Inc
🇩🇪XFRA.1VTGermanyHealthcare
€26.45EURup +0.70 (+2.72%)OpenEnd of day7:05 AM
Price€26.45+0.70 (+2.72%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US92686J1060
- CUSIP
- Not reported
Company
- Employees
- 65
- Headquarters
- San Diego, United States
- CEO
- Dr. Brian Lian Ph.D.
Market
- Shares outstanding
- 116.7M
- Market cap
- €3.09B
Key dates
- Next earnings
- Oct 28, 2026
Highlights
- Market cap
- €3.09B
- EPS LTM
- -$4.61
- P/E LTM
- -8.46
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $00%unchanged year on year
- Net income
- -$534.8M-211.75%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$418.44M-174.32%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.